剂量组学与基因组学在肺癌患者放射性淋巴细胞减少中的相互作用
本研究纳入186例接受放化疗的非小细胞肺癌患者,分析质子与光子随机试验中剂量空间模式与XRCC1-rs25487基因型的交互作用。基于体素分析发现,变异AA基因型与淋巴细胞耗竭相关(p=0.03),且剂量与基因型共同影响淋巴器官区域。
要点
- 在186例非小细胞肺癌放化疗患者中,XRCC1-rs25487 AA基因型与淋巴细胞耗竭相关(p=0.03)。
- 体素分析识别出淋巴器官及富血池器官中剂量与放射性淋巴细胞减少相关的三维区域。
- 研究提示剂量组学与基因组学交互作用可能有助于制定个体化放疗的淋巴细胞减少缓解策略。
核心结论
- 分析盲态突显了放疗期间对淋巴细胞耗竭贡献最大的相关解剖区域,以及变异XRCC1-rs25487 AA基因型与原发淋巴器官受照剂量的交互作用。
- 这些发现可能有助于指导剂量学放射性淋巴细胞减少缓解策略的开发,以应用于有效的个体化放疗。
研究设计与样本
- 研究纳入186例接受放化疗的非小细胞肺癌患者,患者来自质子与光子随机试验,具有基线和放疗期间的绝对淋巴细胞计数及XRCC1-rs25487基因分型数据。
- 掩膜GTV后,将计划CT扫描和剂量图空间归一化至共同解剖参考,采用体素分析评估剂量组学和基因组学解释变量与放射性淋巴细胞减少的体素水平关系。
- 广义线性模型纳入解释变量(三维剂量分布和XRCC1-rs25487基因型)及与放射性淋巴细胞减少显著相关的可能混杂变量,生成模型系数图及其显著性图。
主要发现
- 表征了放疗期间放射性淋巴细胞减少的定义指标,包括淋巴细胞丢失的动力学参数。
- 体素分析生成了放射性淋巴细胞减少与淋巴器官及富血池器官剂量的三维相关性图。
- 识别的体素水平关系考虑了XRCC1-rs25487多态性,并显示变异AA基因型对淋巴细胞耗竭有害(p = 0.03)。
关键数值与推荐
- XRCC1-rs25487变异AA基因型与淋巴细胞耗竭相关(p = 0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the interplay between spatial dose patterns and single nucleotide polymorphisms in the development of radiation-induced lymphopenia (RIL) in 186 non-small-cell lung cancer (NSCLC) patients undergoing chemo-radiotherapy (RT). METHODS: This study included NSCLC patients enrolled in a randomized trial of protons vs. photons with available absolute lymphocyte counts at baseline and during RT and XRCC1-rs25487 genotyping data. After masking the GTV, planning CT scans and dose maps were spatially normalized to a common anatomical reference. A Voxel-Based Analysis (VBA) was performed to assess voxel-wise relationships of dosiomic and genomic explanatory variables with RIL. The underlying generalized linear model was designed to include both the explanatory variables (3D dose distributions and the XRCC1-rs25487 genotypes) and possible nuisance variables significantly correlated with RIL. The maps of model coefficients as well as their significance maps were generated. RESULTS: Measures for RIL definition during RT were characterized, including kinetic parameters for lymphocyte loss. The VBA generated three-dimensional maps of correlation between RIL and dose in lymphoid organs as well as organs with abundant blood pools. The identified voxel-wise relationships account for XRCC1-rs25487 polymorphism and demonstrate the variant AA genotype being detrimental to lymphocyte depletion (p = 0.03). CONCLUSION: The performed analyses blindly highlighted relevant anatomical regions that contributed most to lymphocyte depletion during RT and the interplay of the variant XRCC1-rs25487 AA genotype with the dose delivered to the primary lymphoid organs. These findings may help to guide the development of dosimetric RIL mitigation strategies for the application of effective individualized RT.
引用
- Monti S, Xu T, Liao Z, et al. On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients. Radiother Oncol. 2021. PMID: 34979216. doi:10.1016/j.radonc.2021.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。